Lynwood Capital Management Inc. / MDGL
Lynwood Capital Management Inc.’s Madrigal Pharmaceuticals Inc Position
Does Lynwood Capital Management Inc. own Madrigal Pharmaceuticals Inc (MDGL)? Not currently — the last reported position was 5.0K shares worth $730,200 in Q3 2023; the fund’s latest 13F (Q1 2024) no longer reports it.
Position Value
$730,200
Q3 2023
Shares
5.0K
% of Portfolio
+1.92%
Quarters Held
1
position exited
Position History MDGL
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 5.0K | $730,200 | +1.92% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lynwood Capital Management Inc.’s full portfolio or all institutional holders of MDGL.